Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04946
Species: Homo sapiens
Position : chr14:72448647-72451627
Year: 2026
Title: Mendelian randomization facilitates identification of schizophrenia risk enhancer RNAs.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Schizophrenia
PMID:  41276612
MONDO: MONDO:0005090
Tissue: dorsolateral prefrontal cortex
Tissue Ontology ID: UBERON:0009834
Cell Source: BrainSeq Phase 1 postmortem dorsolateral prefrontal cortex
Experiment Type: Enhancer activity-associated transcription analysis; Genetic association analysis; eQTL analysis; Mendelian randomization analysis; Disease-variant functional analysis
High Throughput Method: RNA-seq; SNP genotyping and imputation; cis-eQTL mapping; PGC3 schizophrenia GWAS integration; Summary-data-based Mendelian Randomization (SMR); eQTL analysis; GWAS
Low Throughput Method: 3C
About Target Gene
Target gene : NA
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_04929 chr14:72448647-72451627 NA neuroblastoma cell Schizophrenia
Expression of Target Genes for the Enhancer